How Do You Treat High MCV? Causes and Treatment Strategies

Treating a high MCV starts with finding out why it is high, because the number itself is a symptom, not a disease. MCV measures the average size of your red blood cells, and when it climbs above roughly 100 femtoliters the condition is called macrocytosis. In one study of 178 people with macrocytosis, alcohol use, vitamin B12 deficiency, and medications together explained about three-quarters of cases.¹ The treatment that brings your MCV back to normal depends entirely on which of those causes, or a less common one, is behind it.

Two Broad Categories of Macrocytosis

Doctors generally sort macrocytosis into two buckets. The first is megaloblastic macrocytosis, where a shortage of vitamin B12 or folate (or a problem using them) slows down DNA copying inside developing red blood cells. Because the cell’s DNA replication lags while the rest of the cell keeps growing, the cell ends up oversized by the time it enters the bloodstream.² The second bucket is nonmegaloblastic macrocytosis, where the red blood cells are large for other reasons: liver disease altering their membranes, alcohol damaging them directly, thyroid problems slowing production, or medications interfering with cell division.²

This distinction matters because the treatment paths are completely different. A person with megaloblastic anemia from B12 deficiency needs B12 replacement, not a change in drinking habits. Someone whose MCV is elevated because of a medication might need a dose adjustment or a switch to a different drug. Getting the category right is the first step toward getting the treatment right.

Vitamin B12 and Folate Deficiency

B12 deficiency is one of the most common and most fixable causes of a high MCV. It accounted for about a quarter of macrocytosis cases in the study mentioned above, and it was the cause most likely to be accompanied by actual anemia.¹ When B12 is low, developing red blood cells in the bone marrow become visibly abnormal: they are oversized, their nuclei look immature relative to the rest of the cell, and the marrow itself becomes packed with these so-called megaloblasts.³

Treatment for B12 deficiency is straightforward: replace the B12. If the problem is dietary (common in strict vegans or people with very limited diets), high-dose oral supplements often work. If the problem is absorption, as in pernicious anemia or after gastric surgery, intramuscular B12 injections are the standard approach, typically given frequently at first and then tapering to once a month for maintenance. Most people see their blood counts start improving within a week or two, though the MCV itself can take a couple of months to fully normalize.

Folate deficiency produces a nearly identical picture on blood work. Treatment is oral folic acid supplementation, usually 1 to 5 mg per day. One important caution: if a person is deficient in both B12 and folate, supplementing only folate can mask the blood-related signs of B12 deficiency while allowing the neurological damage from B12 deficiency to progress silently. Doctors typically check both vitamins before starting treatment, and if there is any doubt, B12 is replaced first or alongside folate.

Alcohol and Liver Disease

Alcohol use was the single most common cause of macrocytosis in that same study, responsible for over a third of cases.¹ Alcohol affects red blood cells through multiple pathways at once. It has a direct toxic effect on the bone marrow, it often coexists with poor nutrition (including folate deficiency), and it damages the membranes of circulating red blood cells. Research on chronic alcohol use shows increased lipid peroxidation and altered cholesterol-to-phospholipid ratios in red blood cell membranes, changes that distort their shape and size.⁴

Liver disease, whether caused by alcohol or something else, creates a separate but related problem. When the liver is damaged, the lipid composition of blood changes, and red blood cell membranes absorb extra cholesterol from the bloodstream. Studies of patients with severe liver disease have found abnormally high cholesterol-to-phospholipid ratios in their red cell membranes, which makes the cells stiffer and larger.⁵ These “spur cells” and “target cells” are classic findings on a blood smear in liver disease.

The treatment here is addressing the underlying cause. For alcohol-related macrocytosis, the MCV usually starts drifting back toward normal within two to four months of sustained abstinence. Any coexisting nutritional deficiencies, especially folate, should be corrected at the same time. For liver disease from other causes, managing the liver condition itself is the priority; the MCV generally improves as liver function stabilizes.

Medications That Can Raise MCV

A number of commonly prescribed medications raise MCV as a side effect, and this is worth knowing because it often does not require any treatment beyond awareness. Drugs that interfere with DNA synthesis are the usual culprits. Methotrexate, widely used for rheumatoid arthritis and other autoimmune conditions, is a well-known example. In a retrospective study of over 1,100 rheumatoid arthritis patients starting methotrexate, about one in five developed macrocytosis (MCV above 100 fL), and in roughly two-thirds of those who developed it, the elevation persisted throughout treatment.⁶ The risk went up with higher methotrexate doses and with the addition of certain other drugs like sulfasalazine or leflunomide.

Other medications frequently linked to macrocytosis include anticonvulsants like valproic acid and phenytoin, certain antiretroviral drugs used for HIV (particularly zidovudine), hydroxyurea (used in sickle cell disease and some blood cancers), and some chemotherapy agents. In the original macrocytosis study, drug-related cases accounted for about 13% of the total.¹

When a medication is clearly the cause and the patient is not anemic, doctors often leave the MCV alone and simply monitor it. The raised MCV is a known and expected side effect, not a sign of harm in most cases. If the MCV climbs very high or anemia develops, the options include reducing the dose, adding folic acid supplementation (methotrexate-related macrocytosis responds to this), or switching to a different medication. The decision depends on how important the drug is for the patient’s underlying condition.

Thyroid Problems and MCV

Hypothyroidism (an underactive thyroid) is another recognized cause of macrocytosis, though the relationship is a bit less clear-cut than with B12 or alcohol. A study comparing patients with overt and subclinical hypothyroidism found that MCV was significantly increased in both groups compared to controls.⁷ And a large cross-sectional analysis using U.S. national health survey data found that lower thyroid hormone levels were consistently associated with higher MCV values, even after adjusting for other factors. People in the highest MCV quartile had meaningfully lower levels of free T3 and total T3 than those in the lowest quartile.⁸

That said, at least one smaller study of thyroid dysfunction found no significant difference in MCV specifically, though other red blood cell measures were affected.⁹ The inconsistency across studies suggests the effect on MCV is real but modest, and it likely depends on how severe and how longstanding the hypothyroidism is.

The treatment is thyroid hormone replacement, typically levothyroxine. As thyroid levels normalize over weeks to months, MCV tends to come down on its own. If a doctor discovers both hypothyroidism and a high MCV, treating the thyroid problem first and rechecking the blood count is a reasonable approach before looking for additional causes.

How Doctors Figure Out the Cause

When a routine blood count comes back with a high MCV, the diagnostic workup is about narrowing down which of the causes above (and a few rarer ones) is responsible. A good starting point is the combination of MCV and another value called the RDW, which measures how much variation there is in red blood cell size. The pairing of MCV and RDW creates a useful grid for differential diagnosis: a high MCV with a normal RDW points to different conditions than a high MCV with a high RDW.¹⁰ The RDW essentially measures whether the red blood cells are uniformly large (suggesting a chronic, steady process) or a mix of sizes (suggesting something more dynamic, like active nutrient replacement or multiple simultaneous problems).¹¹

From there, most doctors will order a peripheral blood smear (looking at the red cells under a microscope), serum B12 and folate levels, a reticulocyte count, liver function tests, and a thyroid panel. The reticulocyte count is particularly useful because reticulocytes, the young red blood cells freshly released from the bone marrow, are naturally larger than mature cells. A high reticulocyte count from active bleeding or red blood cell destruction can push the MCV up all by itself, and this is a completely different situation than a nutritional deficiency.¹²

One subtlety that catches many people off guard: a normal B12 blood level does not completely rule out B12 deficiency. In a study of patients with confirmed cobalamin deficiency (either pernicious anemia or prior stomach surgery), a serum B12 measurement was low in only about 69% of cases, while the metabolite methylmalonic acid was abnormal more than twice as often.¹³ Methylmalonic acid and homocysteine levels are better indicators of whether B12 and folate are actually functioning at the tissue level.¹⁴ In a larger analysis of over 400 episodes of confirmed B12 deficiency, methylmalonic acid was elevated in over 98% of cases, even when standard B12 levels looked fine. The MCV itself was normal in 17% of those with proven B12 deficiency.¹⁵ This means the MCV can be high without B12 deficiency, and B12 deficiency can exist without a high MCV. The blood work has to be read as a package.

When No Obvious Cause Turns Up

In roughly one in four cases, a standard workup does not immediately identify the cause of a high MCV. In the macrocytosis evaluation study, 41 out of 178 cases remained unexplained after testing for the common culprits.¹ Several less common possibilities deserve a mention.

Myelodysplastic syndromes are a group of bone marrow disorders in which the marrow produces abnormal blood cells, often including oversized red blood cells. These conditions are more common in older adults and are usually diagnosed through a bone marrow biopsy when the routine blood work does not add up. Treatment depends on the specific subtype and can range from watchful waiting to chemotherapy or stem cell transplant.

Copper deficiency is a sneaky and underrecognized cause of macrocytic anemia. It can develop in people who take high doses of zinc supplements (because zinc blocks copper absorption in the gut), after certain gastrointestinal surgeries, or in people on prolonged parenteral nutrition. A case report documented a patient whose macrocytic anemia resolved after zinc supplementation was stopped and oral copper replacement was started; hemoglobin normalized and MCV steadily decreased during follow-up.¹⁶ Recognizing it early matters, because most cases respond well to copper replacement combined with reducing excess zinc intake.¹⁷

And sometimes, the MCV reading itself is slightly misleading. Automated blood analyzers can produce spurious MCV values in certain conditions: cold agglutinins (antibodies that cause red cells to clump at low temperatures), very high blood sugar, high salt concentrations in the sample, and other technical factors can all falsely inflate the number.¹⁸ If a mildly elevated MCV does not fit the clinical picture at all, it is worth repeating the test or examining a blood smear directly to confirm the finding is real.

Age and MCV

One factor that often gets overlooked in conversations about high MCV is age itself. MCV gradually increases as people get older, even in people without anemia or any identifiable disease. A large single-institution analysis found that MCV rises steeply during childhood and adolescence (up to about age 25), then continues to creep upward much more slowly through older adulthood. Among adults over 40, men tended to have slightly higher MCV values than women.¹⁹ A separate study of elderly Chinese adults found that MCV, along with several other red blood cell indices, was higher in the group aged 60 and above.²⁰

This age-related drift means an MCV of, say, 101 fL in a 75-year-old is a different finding than the same number in a 30-year-old. In the older patient, it could simply reflect the normal biology of aging rather than a pathological cause. Whether this warrants any treatment is a judgment call. If the number is only mildly elevated, the patient feels well, and the standard workup is unremarkable, monitoring over time without intervention is a perfectly reasonable approach. The standard lab reference ranges for MCV do not always account for age, so it helps to know that a slight upward drift is expected.

When High MCV Does Not Cause Anemia

It is worth knowing that a high MCV and anemia are not the same thing. You can have large red blood cells and still have a normal hemoglobin and red blood cell count. The methotrexate study illustrates this well: anemia coexisted in only about 20% of patients who developed macrocytosis from the drug.⁶ Similarly, in the overall macrocytosis study, anemia was present in only about half of patients.¹

Macrocytosis without anemia still deserves investigation because it can be an early signal of B12 deficiency, alcohol-related organ damage, or another condition that will worsen over time. But the urgency is different. A person with a mildly high MCV, no anemia, and no symptoms is not in immediate danger. The finding is a prompt to look for an underlying cause, not a reason to panic. If the cause turns out to be a medication or the natural drift of aging, the answer might be: keep an eye on it and recheck in a few months.

1
PubMed Central. Evaluation of macrocytosis in routine hemograms
2
PubMed Central. Diagnosis and treatment of macrocytic anemias in adults
3
Frontiers in Nutrition. Revisiting the hematological manifestations of vitamin B12 deficiency
4
PubMed Central. Association between alcohol-induced erythrocyte membrane alterations and hemolysis in chronic alcoholics
5
PubMed. Membrane lipid composition of red blood cells in liver disease: regression of spur cell anaemia after infusion of polyunsaturated phosphatidylcholine
6
PubMed Central. An erythrocyte macrocytosis by methotrexate is associated with early initiation of biologic or targeted synthetic agents in patients with rheumatoid arthritis
7
PubMed Central. Comparison of hematological parameters in untreated and treated subclinical hypothyroidism and primary hypothyroidism patients
8
PubMed Central. Associations among thyroid hormone levels and mean corpuscular volume in adults in the US
9
PubMed Central. Effect of Thyroid Dysfunctions on Blood Cell Count and Red Blood Cell Indice
10
PubMed. Evaluation of erythrocyte disorders with mean corpuscular volume (MCV) and red cell distribution width (RDW)
11
Archives of Internal Medicine. The Automated Complete Blood Cell Count: Use of the Red Blood Cell Volume Distribution Width and Mean Platelet Volume in Evaluating Anemia and Thrombocytopenia
12
PubMed Central. Megaloblastic anemia and other causes of macrocytosis
13
PubMed. Diagnosis of cobalamin deficiency: II. Relative sensitivities of serum cobalamin, methylmalonic acid, and total homocysteine concentrations
14
Clinical Chemistry. Cobalamin and Folate Evaluation: Measurement of Methylmalonic Acid and Homocysteine vs Vitamin B12 and Folate
15
The American Journal of Medicine. Sensitivity of serum methylmalonic acid and total homocysteine determinations for diagnosing cobalamin and folate deficiencies
16
PubMed Central. Hyperregenerative macrocytic anaemia: the role of copper and zinc
17
PubMed. Discovering the hidden link: hematological disorders caused by copper deficiency
18
PubMed. Spurious counts and spurious results on haematology analysers: a review. Part II: white blood cells, red blood cells, haemoglobin, red cell indices and reticulocytes
19
PubMed Central. Age-related changes in mean corpuscular volumes in patients without anaemia
20
PubMed. Erythropoiesis changes with increasing age in the elderly Chinese